复星医药(600196.SH)：法莫替丁注射液药品获注册批准

Group 1 - The core point of the article is that Fosun Pharma's subsidiary, Jinzhou Aohong Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application of Famotidine Injection [1] - The approved indication for the drug is for the treatment of upper gastrointestinal bleeding caused by peptic ulcers, excluding those due to tumors and esophageal or gastric varices [1] - The drug is a chemically synthesized product developed independently by the company and its subsidiaries [1]